Organization · Venture Capital
Cambridge Innovation Capital
Cambridge Innovation Capital is a venture capital firm based in Cambridge, UK, focusing on early-stage investments in life sciences and deep tech sectors. It leverages its relationship with the University of Cambridge to identify promising startups.
Overview
What Cambridge Innovation Capital does
What Cambridge Innovation Capital is
Cambridge Innovation Capital is a venture capital firm based in Cambridge, UK, focusing on early-stage investments in life sciences and deep tech sectors. It leverages its relationship with the University of Cambridge to identify promising startups.
How it participates in the startup ecosystem
The current public profile supports funder and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2014
- Approximate age
- About 12 years
- Structured capabilities
- Funder · Event host · Publisher
- Last reviewed
- March 16, 2026
Official channels
Find Cambridge Innovation Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Cambridge Innovation Capital as a funder
Investment thesis
Cambridge Innovation Capital (CIC) focuses on the commercialization of life sciences and deep tech innovations, leveraging its unique relationship with the University of Cambridge to access promising investment opportunities.
Focus narrative
CIC primarily invests in early-stage companies, focusing on Seed through Series A funding. The firm supports entrepreneurs in balancing technology development with business growth, particularly in sectors such as cancer therapy, genomic diagnosis, surgical robotics, artificial intelligence, and quantum computing. CIC also offers later-stage support through opportunity and growth funds, providing scale-up capital.
Value beyond capital
CIC adds value to its portfolio companies by providing access to a robust network within the University of Cambridge ecosystem, offering technical expertise, strategic guidance, and opportunities for collaboration with leading researchers and institutions.
Terms and economics
- Typical check
- $1,000,000–$10,000,000
- Sweet spot
- $5,000,000
Focus and fit
- Stages
- Seed · Series A · Series A+
- Sectors
- Biotech & Life SciencesArtificial IntelligenceRobotics & Autonomous SystemsHealthcareGenomicsDrug Discovery
- Regions
- EuropeUnited Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 30
Portfolio context
CIC's portfolio includes notable companies such as: Cambridge GaN Devices: Focuses on sustainable power electronics. Pragmatic Semiconductor: Innovates in semiconductor technology and manufacturing. Riverlane: Develops error correction technology for quantum computing. Microbiotica: Works on microbiome-based treatments. BeyondMath: Aims to unlock innovation through generative physics. Cytora: Powers digital insurance solutions. TRIMTECH Therapeutics: Targets neurodegenerative diseases.
Capability profile
Cambridge Innovation Capital as an event host
Event focus
Cambridge Innovation Capital (CIC) invests primarily in early-stage companies, specifically from Seed through Series A funding. The firm supports entrepreneurs in balancing technology development with business growth. Its investment strategy encompasses sectors such as cancer therapy, genomic diagnosis, surgical robotics, artificial intelligence, and quantum computing. CIC also provides later-stage support through opportunity and growth funds, offering scale-up capital and technical expertise.
Format and cadence
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Stages
- Seed · Series A
- Audience
- Founders · Investors
- Regions
- United Kingdom
Capability profile
Cambridge Innovation Capital as a publisher
Editorial focus
Cambridge Innovation Capital (CIC) is dedicated to the commercialization of life sciences and deep tech innovations. Founded in 2014 and based in Cambridge, UK, CIC leverages its unique relationship with the University of Cambridge to access promising investment opportunities within a leading science and technology ecosystem. The firm primarily invests in early-stage companies, supporting entrepreneurs in balancing technology development with business growth.
Audience value
CIC provides scale-up capital and technical expertise to early-stage companies, helping them navigate the challenges of technology development and business growth.
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Founders · Investors
- Regions
- EuropeUnited Kingdom
Flagship work and coverage
Flagship properties
CIC publishes insights and news related to its portfolio and the broader innovation ecosystem. It also hosts events such as 'From Idea to Start-up: Founders & Investors in Conversation.'
Common questions
What to know about Cambridge Innovation Capital
Upseed classifies Cambridge Innovation Capital under the Venture Capital organization type. Its current public profile includes funder, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.